Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma.

Kratzsch, Jürgen; Willenberg, Anja; Frank-Raue, Karin; Kempin, Uwe; Rocktäschel, Jörg; Raue, Friedhelm

Kratzsch, Jürgen; Willenberg, Anja; Frank-Raue, Karin; Kempin, Uwe; Rocktäschel, Jörg; Raue, Friedhelm.

Afiliação

Kratzsch J; Institute for Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.
Willenberg A; Institute for Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.
Frank-Raue K; Endocrine Practice, Heidelberg, Germany.
Kempin U; pes Gesellschaft für medizinische Diagnose-Systeme mbH, Markkleeberg, Germany.
Rocktäschel J; pes Gesellschaft für medizinische Diagnose-Systeme mbH, Markkleeberg, Germany.
Raue F; Endocrine Practice, Heidelberg, Germany.

Clin Chem Lab Med ; 59(11): 1861-1868, 2021 10 26.

Article em En | MEDLINE | ID: mdl-34256421

Assuntos

Carcinoma Neuroendócrino; Neoplasias da Glândula Tireoide; Biomarcadores Tumorais; Carcinoma Neuroendócrino/diagnóstico; Seguimentos; Humanos; Pró-Calcitonina; Neoplasias da Glândula Tireoide/patologia

Palavras-chave

calcitonin; medullary thyroid cancer (MTC); multiple endocrine neoplasia type 2 (MEN2); procalcitonin; tumor marker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google